Drawing for HYPROTECAN

USPTO serial 99751307

HYPROTECAN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JEONG, SO YOUNG
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with HYPROTECAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RAN HE

10190 Harwin Dr. Ste B,Houston, TX 77036United States

Goods and services

ClassDescriptionStatusFirst use
005Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer; Preparations of microorganisms for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 22, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 26, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 26, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Aug 26, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 26, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 18, 2026DOCKASSIGNED TO EXAMINER—
Aug 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance